Cellectar Biosciences, Inc. (CLRB)
2.38
-0.03
(-1.24%)
USD |
NASDAQ |
Sep 09, 13:39
Cellectar Biosciences Price : 2.38 for Sept. 9, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 08, 2026 | 2.46 | 2.47 | 2.375 | 2.41 | 27558.00 |
| Sep 04, 2026 | 2.33 | 2.40 | 2.33 | 2.37 | 26575.00 |
| Sep 03, 2026 | 2.39 | 2.44 | 2.34 | 2.35 | 70008.00 |
| Sep 02, 2026 | 2.46 | 2.50 | 2.42 | 2.43 | 48766.00 |
| Sep 01, 2026 | 2.48 | 2.54 | 2.45 | 2.46 | 46427.00 |
| Aug 31, 2026 | 2.52 | 2.55 | 2.49 | 2.51 | 17294.00 |
| Aug 28, 2026 | 2.55 | 2.55 | 2.51 | 2.53 | 23836.00 |
| Aug 27, 2026 | 2.57 | 2.57 | 2.52 | 2.54 | 10321.00 |
| Aug 26, 2026 | 2.46 | 2.59 | 2.46 | 2.54 | 13202.00 |
| Aug 25, 2026 | 2.59 | 2.60 | 2.50 | 2.54 | 16671.00 |
| Aug 24, 2026 | 2.56 | 2.590 | 2.50 | 2.52 | 23171.00 |
| Aug 21, 2026 | 2.600 | 2.60 | 2.50 | 2.59 | 26653.00 |
| Aug 20, 2026 | 2.620 | 2.62 | 2.50 | 2.59 | 32803.00 |
| Aug 19, 2026 | 2.61 | 2.70 | 2.61 | 2.62 | 56240.00 |
| Aug 18, 2026 | 2.51 | 2.60 | 2.51 | 2.59 | 31344.00 |
| Aug 17, 2026 | 2.63 | 2.66 | 2.56 | 2.56 | 51051.00 |
| Aug 14, 2026 | 2.50 | 2.636 | 2.50 | 2.60 | 46622.00 |
| Aug 13, 2026 | 2.51 | 2.64 | 2.45 | 2.48 | 30388.00 |
| Aug 12, 2026 | 2.57 | 2.63 | 2.57 | 2.60 | 27992.00 |
| Aug 11, 2026 | 2.57 | 2.65 | 2.552 | 2.64 | 20552.00 |
| Aug 10, 2026 | 2.61 | 2.61 | 2.56 | 2.60 | 31899.00 |
| Aug 07, 2026 | 2.52 | 2.590 | 2.49 | 2.57 | 16081.00 |
| Aug 06, 2026 | 2.47 | 2.63 | 2.47 | 2.52 | 18524.00 |
| Aug 05, 2026 | 2.66 | 2.66 | 2.485 | 2.52 | 24405.00 |
| Aug 04, 2026 | 2.70 | 2.70 | 2.53 | 2.56 | 38806.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 27.81 |
| Alnylam Pharmaceuticals, Inc. | 255.29 |
| Anika Therapeutics, Inc. | 20.88 |
| Savara, Inc. | 5.395 |
| Vericel Corp. | 38.82 |
Price Related Metrics
| Price to Book Value | 0.6575 |
| Earnings Yield | -191.4% |
| Market Cap | 19.64M |